Engagement within the new system

988 views
875 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
988
On SlideShare
0
From Embeds
0
Number of Embeds
716
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Engagement within the new system

  1. 1. Engagement within the new system Paul McManus, Lead Pharmacist | Specialised Commissioning
  2. 2. Engagement within the new system Paul McManus Lead pharmacist - specialised services South Yorkshire and Bassetlaw Area Team ABPI Regional event June 2013
  3. 3. NHS | Presentation to [XXXX Company] | [Type Date]3
  4. 4. Opportunities for engagement Product specific National • research • pipeline • commissioning • value • price • placement 4 Local • implementation • price • priorities • problems
  5. 5. Medicines optimisation Medicines still most common therapeutic intervention and biggest cost after staff, but, for example: • 30 to 50% not taken as intended • Patients have insufficient supporting information • UK Literature suggests 5 to 8% of hospital admissions due to preventable adverse effects of medicines • Medication errors across all sectors and age groups at unacceptable levels • Medicines wastage in primary care: £300M pa with £150M pa avoidable • Relatively little effort towards understanding clinical effectiveness of medicines in real practice • The threat of antimicrobial resistance
  6. 6. National Reporting and Learning System for England and Wales Types of incidents 2005-10 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
  7. 7. NRLS in England and Wales medication incident reports 2005 - 10 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
  8. 8. NRLS – who is reporting incidents? 8 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
  9. 9. NRLS – Critical medicines Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012 NRLS – Critical medicines
  10. 10. NRLS – Error category Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
  11. 11. Medicines Optimisation Principles
  12. 12. A strategy might include… • Patient engagement • Collaborative working across health economies • Improving outcomes • Value for money • Partnership with industry • Medicines pathway • Safety and assurance 12 Information and technology
  13. 13. What can we do? • Be an active commissioner • Ensure contact at right level and make meetings productive for all • Look for ways to best use skills and resources available • Think beyond individual products • Start talking 13
  14. 14. Engagement within the new system paulmcmanus@nhs.net 14

×